Blood Flow Restriction & Tennis Elbow Rehab
Launched by JULIE NUELLE · Feb 2, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help people with tennis elbow, also known as lateral epicondylitis. This condition causes pain on the outside of the elbow and often affects those who use their arms a lot, leading to weakness and discomfort. The trial aims to find out if a method called blood flow restriction therapy can help reduce pain quickly and improve recovery for patients. Researchers want to learn more about effective treatments since current options aren’t always helpful.
To participate in this study, you need to be between 18 and 65 years old and have a confirmed diagnosis of tennis elbow from an orthopedic surgeon. You should also be able to read and write in English and give your consent to participate. Unfortunately, if you're over 65, have certain medical conditions, or have had specific treatments in the past year, you won’t be eligible for this trial. If you qualify, you can expect to take part in a program designed to help your elbow heal, and you'll be closely monitored throughout the process. This study is currently looking for participants, so if you think you might fit the criteria, it could be a good opportunity to help improve treatments for tennis elbow.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Ages 18-65 years of age
- • 2. Diagnosis of lateral epicondylitis confirmed by the treating orthopaedic surgeon and ultrasound
- • 3. Must be able to read and write in English
- • 4. Able to provide own written consent
- Exclusion Criteria:
- • 1. Patients over 65 years of age
- • 2. Contralateral upper extremity involvement resulting in less than normal range of motion, muscle strength or daily pain greater than 1/10
- • 3. History of prior injection for treatment of lateral epicondylitis
- • 4. Pregnancy
- • 5. Recent history of deep venous thrombosis (within the past 12 months)
- • 6. Active treatment with anticoagulants
- • 7. History of upper quadrant lymph node dissection
- • 8. History of endothelial dysfunction
- • 9. Patient history of easy bruising
- • 10. Active infection in the injured arm
- • 11. Cancer
- • 12. Uncontrolled peripheral vascular disease
- • 13. Uncontrolled diabetes mellitus
About Julie Nuelle
Julie Nuelle is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and a collaborative approach, Julie Nuelle facilitates the design, execution, and management of clinical trials across various therapeutic areas. Leveraging a robust network of clinical sites and experienced professionals, the organization prioritizes ethical standards, regulatory compliance, and patient safety, ensuring that each study contributes valuable insights to the medical community. Through strategic partnerships and a patient-centered ethos, Julie Nuelle aims to drive meaningful advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Columbia, Missouri, United States
Patients applied
Trial Officials
Julia Nuelle, MD
Principal Investigator
University of Missouri Department of Orthopaedic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials